Page 63 - Live-cellanalysis handbook
P. 63

Kinetic Transendothelial Migration Assays


           Inhibition of leukocyte extravasation
           For AMD3100 (CXCR4 receptor antagonist) and BIRT377 (allosteric   were then plated at a density of 5,000 cells per well on to a HUVEC
           modulator of LFA- 1) inhibition studies, CD3/CD28 activated   monolayer then exposed to 100nM SDF-1a (EC80concentration).
           T-cells were pre-treated for 1 hour at 37°C at indicated inhibitor   Images were collected every hour over a 12 hour period and phase
           concentrations, then seeded onto HUVEC monolayers and exposed   analysis performed.
           to 100nM SDF-1a (Figure 5A and C).
                                                                  The observed increase in total cell area is due to proliferation of
           Analysis of AMD3100 pharmacological response was performed at   C3/CD28 activated T cells. The inability to fully inhibit TEM via
           t=6 hr. Each data point represents mean ± SEM, N=4 (Figure 5B).   BIRT 377 and neutralizing ICAM-1 is believed to be caused by the
           For antibody inhibition, HUVEC monolayers cultured overnight   centrifugation step, bringing the T cells to the HUVEC monolayer,
           on fibronectin were ± pre-treated with neutralizing ICAM-1 for   thus bypassing the cell adhesion step.
           1 hour at 37°C (Figure 5D). CD3/CD28 Dynabead activated T cells


            A                                                      B
















            C                                                      D


















           Figure 5. Treatment effects on leukocyte transendothelial migration. Inhibition of CXCL12 (SDF-1a) driven T cell migration by AMD3100 (A), BIRT 377
           (C) and neutralizing ICAM-1. Analysis of AMD3100 pharmacological response (B). Migration across the endothelial layer was at least partially dependent
           on ICAM-1, as neutralizing ICAM-1 antibodies, and treatments with an allosteric inhibitor of LFA-1, BIRT377, significantly inhibited SDF-1a mediated
           diapedesis of T cells.


           Conclusions


           The IncuCyte® chemotaxis transendothelial assay can be used for real-time visualization
           and automated analysis of transendothelial migration in a 96-well format, in real-time.

           •    Acquisition of high-definition, phase contrast images ensure endothelium integrity
              throughout the experiment.
           •    Measurement of leukocyte extravasation is automatically processed without use of
              intrinsically toxic dyes, fixing, staining and cell scraping steps.
           •    All data points can be validated by individual images or time-lapse movies to confirm
              processing metrics, significantly enhancing the confidence in the measured response.


                                                                                                                    61
   58   59   60   61   62   63   64   65   66   67   68